end,filed,form,Name,Ticker,CIK,Currency,AccountsPayableCurrent,AccruedLiabilitiesCurrent,AdditionalPaidInCapitalCommonStock,AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition,AllocatedShareBasedCompensationExpense,AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount,Assets,AssetsCurrent,CashAndCashEquivalentsAtCarryingValue,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect,ConversionOfStockAmountConverted1,DeferredOfferingCosts,DefinedContributionPlanEmployerDiscretionaryContributionAmount,DepositsAssetsCurrent,DepreciationAmortizationAndAccretionNet,DueToRelatedPartiesCurrent,EarningsPerShareBasicAndDiluted,EmployeeRelatedLiabilitiesCurrent,EquitySecuritiesFvNi,EquitySecuritiesFvNiGainLoss,EquitySecuritiesFvNiUnrealizedGainLoss,FinanceLeasePrincipalPayments,GainLossOnDispositionOfAssets1,GainLossOnSaleOfBusiness,GeneralAndAdministrativeExpense,IncomeTaxExpenseBenefit,IncreaseDecreaseInAccountsPayable,IncreaseDecreaseInAccruedLiabilities,IncreaseDecreaseInOtherCurrentLiabilities,IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets,InterestExpense,InterestPaid,InvestmentIncomeInterest,Liabilities,LiabilitiesAndStockholdersEquity,LiabilitiesCurrent,MarketableSecuritiesNoncurrent,NetCashProvidedByUsedInFinancingActivities,NetCashProvidedByUsedInInvestingActivities,NetCashProvidedByUsedInOperatingActivities,NetIncomeLoss,NonoperatingIncomeExpense,OperatingExpenses,OperatingIncomeLoss,OperatingLeasesFutureMinimumPaymentsDue,OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentals,OperatingLeasesFutureMinimumPaymentsDueInFiveYears,OperatingLeasesFutureMinimumPaymentsDueInFourYears,OperatingLeasesFutureMinimumPaymentsDueInThreeYears,OperatingLeasesFutureMinimumPaymentsDueInTwoYears,OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear,OtherAccruedLiabilitiesCurrent,OtherAssetsCurrent,PaidInKindInterest,PaymentsForRestructuring,PaymentsOfDebtIssuanceCosts,PaymentsOfStockIssuanceCosts,PaymentsToAcquirePropertyPlantAndEquipment,PreferredStockParOrStatedValuePerShare,PreferredStockSharesAuthorized,PreferredStockSharesIssued,PreferredStockSharesOutstanding,PrepaidExpenseAndOtherAssetsCurrent,PrepaidExpenseCurrent,PrepaidInsurance,ProceedsFromConvertibleDebt,ProceedsFromDivestitureOfBusinesses,ProceedsFromIssuanceOfCommonStock,ProceedsFromStockOptionsExercised,RedeemableNoncontrollingInterestEquityPreferredCarryingAmount,ResearchAndDevelopmentExpense,RestrictedCashCurrent,RestrictedCashNoncurrent,RestructuringCharges,RestructuringCosts,RestructuringReserve,RestructuringReserveCurrent,RestructuringReserveNoncurrent,RestructuringReserveSettledWithoutCash2,RetainedEarningsAccumulatedDeficit,ShareBasedCompensation,ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate,ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum,ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum,ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum,ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice,ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice,ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice,SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1,SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares,SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares,StockholdersEquity,StockholdersEquityNoteStockSplitConversionRatio1,StockIssuedDuringPeriodSharesStockOptionsExercised,StockIssuedDuringPeriodValueConversionOfConvertibleSecurities,StockIssuedDuringPeriodValueNewIssues,StockIssuedDuringPeriodValueStockOptionsExercised,TemporaryEquityLiquidationPreference,TemporaryEquityParOrStatedValuePerShare,TemporaryEquitySharesAuthorized,TemporaryEquitySharesIssued,TemporaryEquitySharesOutstanding,WeightedAverageNumberOfShareOutstandingBasicAndDiluted,AccretionExpenseIncludingAssetRetirementObligations,AccruedProfessionalFeesCurrent,AccruedProfessionalFeesCurrentAndNoncurrent,CurrentFederalTaxExpenseBenefit,CurrentIncomeTaxExpenseBenefit,CurrentStateAndLocalTaxExpenseBenefit,DebtInstrumentCarryingAmount,DebtInstrumentInterestRateEffectivePercentage,DeferredFinanceCostsNet,DeferredIncomeTaxExpenseBenefit,DeferredTaxAssetsGoodwillAndIntangibleAssets,DeferredTaxAssetsGross,DeferredTaxAssetsInProcessResearchAndDevelopment,DeferredTaxAssetsLiabilitiesNet,DeferredTaxAssetsNet,DeferredTaxAssetsOperatingLossCarryforwards,DeferredTaxAssetsOperatingLossCarryforwardsDomestic,DeferredTaxAssetsOther,DeferredTaxAssetsPropertyPlantAndEquipment,DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost,DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals,DeferredTaxAssetsValuationAllowance,DeferredTaxLiabilities,IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic,IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest,IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign,IncomeTaxExaminationPenaltiesAndInterestExpense,IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate,IncomeTaxReconciliationOtherAdjustments,IncomeTaxReconciliationStateAndLocalIncomeTaxes,IncomeTaxReconciliationTaxCredits,IncreaseDecreaseInAssetsHeldForSale,IncreaseDecreaseInOtherCurrentAssets,InterestPaidNet,LongTermDebt,LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive,OperatingLeaseLiability,OperatingLeaseRightOfUseAsset,OtherAccruedLiabilitiesCurrentAndNoncurrent,PaymentsToAcquireOtherProductiveAssets,PreferredStockValue,PrepaidExpenseAndOtherAssetsNoncurrent,PrepaidExpenseCurrentAndNoncurrent,PrepaidRent,ProceedsFromSaleOfPropertyPlantAndEquipment,SecuredDebt,UnrecognizedTaxBenefits,UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions,UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued,UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions,UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
2021-03-31,2021-06-24,10-Q,"Vera Therapeutics, Inc.",VERA,CIK0001831828,USD,1440000.0,1798000.0,2845000.0,404000.0,404000.0,17818492.0,51825000.0,51532000.0,49505000.0,49848000.0,-4149000.0,,1294000.0,0.0,,35000.0,299000.0,-12.23,444000.0,,,,1000.0,,,1784000.0,0.0,-198000.0,1069000.0,,127000.0,,,2000.0,5565000.0,51825000.0,3753000.0,,-28000.0,,-4121000.0,-4714000.0,2000.0,4716000.0,-4716000.0,11232000.0,8854000.0,1937000.0,2538000.0,2458000.0,2399000.0,1900000.0,326000.0,81000.0,,590000.0,,369000.0,,,,,,1977000.0,535000.0,,,,,342000.0,139576000.0,2932000.0,50000.0,293000.0,35000.0,,2041000.0,515000.0,1526000.0,,-96161000.0,404000.0,0.0,0.764,0.763,0.008,0.006,63177.0,5.12,,275353.0,8924000.0,1952346.0,3.08,3.01,3.92,180000.0,2015523.0,1654.0,-93316000.0,,113683.0,,,342000.0,139338000.0,0.001,182772372.0,182772372.0,182772372.0,385401.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
2021-06-30,2021-08-16,10-Q,"Vera Therapeutics, Inc.",VERA,CIK0001831828,USD,1723000.0,1688000.0,191732000.0,713000.0,713000.0,2659873.0,97647000.0,95876000.0,91625000.0,91968000.0,,,,0.0,85000.0,,717000.0,-0.33,558000.0,1478000.0,-281000.0,,,,2691000.0,2614000.0,0.0,,,,,,,2000.0,5492000.0,97647000.0,3771000.0,1478000.0,,,,-3437000.0,2412000.0,5849000.0,-5849000.0,10500000.0,8412000.0,1954000.0,2538000.0,2458000.0,2381000.0,1169000.0,413000.0,475000.0,,,,,,0.001,10000000.0,0.0,0.0,4201000.0,,2509000.0,,,,,0.0,3235000.0,50000.0,293000.0,,,1795000.0,360000.0,1435000.0,,-99598000.0,,,0.766,0.763,0.011,0.01,,,,,,,,,,,,,92155000.0,,,139576000.0,48411000.0,208000.0,,0.001,0.0,0.0,0.0,10499937.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
2021-09-30,2021-11-10,10-Q,"Vera Therapeutics, Inc.",VERA,CIK0001831828,USD,964000.0,2711000.0,192665000.0,933000.0,933000.0,2898808.0,91167000.0,89760000.0,86191000.0,86484000.0,,,,0.0,57000.0,,994000.0,-0.36,1051000.0,1114000.0,-364000.0,,,,,3688000.0,0.0,,,,,,,5000.0,5690000.0,91167000.0,4042000.0,1114000.0,,,,-7611000.0,-359000.0,7252000.0,-7252000.0,9916000.0,7925000.0,1953000.0,2537000.0,2458000.0,2381000.0,587000.0,666000.0,786000.0,,,,,,0.001,10000000.0,0.0,0.0,3569000.0,,1837000.0,,,,,,3564000.0,,293000.0,,,1729000.0,367000.0,1362000.0,,-107209000.0,,,0.758,0.754,0.01,0.009,,,,,,,,,,,,,85477000.0,,,,,,,0.001,0.0,0.0,0.0,21265519.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
